Soo Chin

718 total citations
10 papers, 536 citations indexed

About

Soo Chin is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Otorhinolaryngology. According to data from OpenAlex, Soo Chin has authored 10 papers receiving a total of 536 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 5 papers in Pulmonary and Respiratory Medicine and 4 papers in Otorhinolaryngology. Recurrent topics in Soo Chin's work include Head and Neck Cancer Studies (4 papers), Lung Cancer Treatments and Mutations (4 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Soo Chin is often cited by papers focused on Head and Neck Cancer Studies (4 papers), Lung Cancer Treatments and Mutations (4 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Soo Chin collaborates with scholars based in Canada, United States and Australia. Soo Chin's co-authors include Lillian L. Siu, Eric X. Chen, Gregory R. Pond, Eric Winquist, P. Francis, Jennifer J. Knox, Dean Wilkie, Mark Agulnik, Oana Petrenciuc and Malcolm J. Moore and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and European Journal of Cancer.

In The Last Decade

Soo Chin

10 papers receiving 532 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Soo Chin Canada 6 256 199 189 185 170 10 536
Amy Prawira Canada 11 326 1.3× 111 0.6× 147 0.8× 172 0.9× 62 0.4× 38 621
Genevieve A. Andrews United States 9 284 1.1× 90 0.5× 87 0.5× 212 1.1× 84 0.5× 14 492
Junichi Tomomatsu Japan 13 232 0.9× 38 0.2× 158 0.8× 106 0.6× 61 0.4× 49 431
Carrie B. Marshall United States 11 140 0.5× 69 0.3× 129 0.7× 94 0.5× 117 0.7× 20 397
Harlinde De Schutter Belgium 9 97 0.4× 144 0.7× 64 0.3× 179 1.0× 38 0.2× 12 360
Tomohiro Ishikita Japan 10 100 0.4× 118 0.6× 124 0.7× 107 0.6× 74 0.4× 15 432
Tetsuya Urasaki Japan 12 205 0.8× 50 0.3× 107 0.6× 73 0.4× 99 0.6× 53 416
Sunandana Chandra United States 8 250 1.0× 251 1.3× 93 0.5× 348 1.9× 156 0.9× 10 642
Marko Buta Serbia 12 143 0.6× 108 0.5× 143 0.8× 161 0.9× 139 0.8× 42 489

Countries citing papers authored by Soo Chin

Since Specialization
Citations

This map shows the geographic impact of Soo Chin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Soo Chin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Soo Chin more than expected).

Fields of papers citing papers by Soo Chin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Soo Chin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Soo Chin. The network helps show where Soo Chin may publish in the future.

Co-authorship network of co-authors of Soo Chin

This figure shows the co-authorship network connecting the top 25 collaborators of Soo Chin. A scholar is included among the top collaborators of Soo Chin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Soo Chin. Soo Chin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
O’Kane, Grainne M., Shereen Ezzat, Anthony M. Joshua, et al.. (2019). A phase 2 trial of sunitinib in patients with progressive paraganglioma or pheochromocytoma: the SNIPP trial. British Journal of Cancer. 120(12). 1113–1119. 85 indexed citations
2.
Leibowitz‐Amit, Raya, Anthony M. Joshua, Shereen Ezzat, et al.. (2014). A single-arm, phase II, multicenter trial of sunitinib maleate (SU) in locally advanced or metastatic pheochromocytoma/paraganglioma (PC/PG): Interim results.. Journal of Clinical Oncology. 32(4_suppl). 431–431. 1 indexed citations
3.
Chen, Eric Xueyu, Eric Winquist, Cheryl Ho, et al.. (2014). Vorinostat (VOR) and capecitabine (CAP) in recurrent and/or metastatic squamous cell carcinoma of head and neck (RMHNSCC): A study of the Princess Margaret Phase II Consortium.. Journal of Clinical Oncology. 32(15_suppl). e17001–e17001. 1 indexed citations
4.
Riechelmann, Rachel P., Soo Chin, Lisa Wang, et al.. (2008). Sorafenib for Metastatic Renal Cancer. American Journal of Clinical Oncology. 31(2). 182–187. 41 indexed citations
5.
6.
Elser, Christine, Lillian L. Siu, Eric Winquist, et al.. (2007). Phase II Trial of Sorafenib in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck or Nasopharyngeal Carcinoma. Journal of Clinical Oncology. 25(24). 3766–3773. 183 indexed citations
7.
Knox, Jennifer J., Lillian L. Siu, Eric X. Chen, et al.. (2005). A Phase I trial of prolonged administration of lovastatin in patients with recurrent or metastatic squamous cell carcinoma of the head and neck or of the cervix. European Journal of Cancer. 41(4). 523–530. 86 indexed citations
8.
Durán, Ignacio, Lillian L. Siu, Eric X. Chen, et al.. (2005). Phase I trial of gemcitabine, doxorubicin and cisplatin (GAP) in patients with advanced solid tumors. Anti-Cancer Drugs. 17(1). 81–87. 3 indexed citations
9.
Mäkitie, Antti, Patrícia P. Reis, Jonathan Irish, et al.. (2004). Correlation of Epstein‐Barr virus DNA in cell‐free plasma, functional imaging and clinical course in locally advanced nasopharyngeal cancer: A pilot study. Head & Neck. 26(9). 815–822. 22 indexed citations
10.
Mäkitie, Antti, Patrícia P. Reis, Tong Zhang, et al.. (2004). Epstein-Barr Virus DNA Measured in Nasopharyngeal Brushings in Patients with Nasopharyngeal Carcinoma: Pilot Study. The Journal of Otolaryngology. 33(5). 299–299. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Amy Prawira Breakdown of academic impact, for papers by Genevieve A. Andrews Breakdown of academic impact, for papers by Junichi Tomomatsu Breakdown of academic impact, for papers by Carrie B. Marshall Breakdown of academic impact, for papers by Harlinde De Schutter Breakdown of academic impact, for papers by Tomohiro Ishikita Breakdown of academic impact, for papers by Tetsuya Urasaki Breakdown of academic impact, for papers by Sunandana Chandra Breakdown of academic impact, for papers by Marko Buta
Rankless by CCL
2026